Loading organizations...

§ Venture Capital · Herzliya, Israel
Venture capital firm investing in advanced pre-clinical to early clinical-stage biotechnology and biopharmaceutical companies.
Arkin Bio Ventures is a venture capital firm specializing in life sciences. It invests capital in advanced pre-clinical and early-stage companies developing novel technologies across pharmaceuticals, biotechnology, and medical devices. The firm targets nascent ventures that offer significant potential for innovation in healthcare.
Established around 2010, Arkin Bio Ventures operates as a focused unit under the larger Arkin Capital group. This venture was initiated based on the insight that dedicated financial and strategic support for early-stage life science innovations was crucial. Its formation underscores Arkin Capital's commitment to advancing scientific discovery.
The firm primarily supports early-stage life science companies seeking initial capital and strategic advice. Arkin Bio Ventures aims to empower these enterprises to translate scientific advancements into viable medical products. Its long-term vision is to foster impactful pharmaceutical, biotech, and medical device technologies, addressing critical unmet medical needs.
Key people at Arkin Bio Ventures.
Arkin Bio Ventures has 16 tracked investments across 15 companies. The latest tracked deal is $77.0M Series B in Crossbow Therapeutics in March 2026.
Key people at Arkin Bio Ventures.